BioSpace News Archive

Ansys, the global leader and innovator of engineering simulation software, is establishing its first physical presence in Africa with a new office in Kigali, Rwanda.

Spaulding Clinical, a leading clinical research organization, is expanding its services to include ADME clinical trials.

Tvardi Therapeutics, Inc. today announced that the first patients have been dosed in each arm of its ongoing REVERT LIVER CANCER trial.

Elligo Health Research®, the largest healthcare-enabling research organization, launched an updated version of its IntElligo® Study Marketplace, a technology-enabled solution that supports research sites in building a strong study pipeline.

Beta Bionics, Inc. - a medical technology company focused on diabetes - announces FDA 510(k) clearance for compatibility with the Fiasp Pumpcart (insulin aspart) prefilled insulin cartridge.

Propanc Biopharma, Inc. today announced a shareholder update including recent developments and forecast for 2023/24, as Propanc prepares to file a Form 10-K annual report, whose fiscal year end is June 30.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that its groundbreaking research utilizing DehydraTECH-processed cannabidiol (“DehydraTECH-CBD”) has now been published in eight peer-reviewed articles in six different publications.

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs,

Company Sees Benefits For Healthcare Practitioners, Businesses and Governments To Better Collect, Capture And Analyze Critical Respiratory Data

Management to Host Conference Call at 8:00 Am Eastern Time on Thursday, June 22, 2023